POCT (Chemiluminescense Immunoassay Method)

POCT is short for Point of Care Testing, which can be translated as “on-site real-time testing”. POCT industry belongs to the subdivision of IVD industry and is one of the fastest growing subdivision of IVD industry in recent years. Compared with other in vitro diagnostic products, POCT products have three distinct characteristics: detection time, POCT products shorten the detection cycle from sample collection to result reporting; Detection space, POCT belongs to the detection around the detected object; The operator of POCT can be a non-professional inspector or even the tested object himself. POCT instruments are widely used due to a series of advantages such as portability, easy operation and timely and accurate results. POCT detection products for cardiovascular diseases are mainly used for rapid quantitative or qualitative screening of common cardiovascular diseases (myocardial infarction, heart failure, etc.). Including cardiac troponin I (CTnI), cardiac troponin T (CTnT) myoglobin, creatine kinase isoenzyme (CK-MB), B-type natriuretic peptide (BNP), cardiac fatty acid binding protein (H-FABP), N-terminal B-type natriuretic peptide precursor (NT-probNP), D-dimer (D-Dimer), lipoprotein phase Phospholipase A2 (LP-PLA2), growth stimulating factor 2 (ST2), S100-β protein. POCT detection products for inflammatory and infectious diseases are mainly used to quickly judge the existence of infection and infer the types of possible pathogens, including procalcitonin (PCT), interleukin-6 (IL-6) and heparin binding protein (HBP).